Stämm Biotech
Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, and repeatable. Inspired by nature, we have developed the first methodology for continuous industrial production of biologics and cell therapies leveraging microfluidics and 3D printing. Founded in 2016, Stämm mimics nature’s use of laminar flow to down-size a whole biotech facility into an all-in-one, plug & play desktop unit. Our focus is to decentralize bioprocesses and democratize access to biotechnology products, thus freeing our partners to focus on the disruptive discoveries that make an impact in people’s life.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Research
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2016
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Throughout the last 12000 years, the amount of biomass in the world was cut in half, and in the last 100 years, the amount of anthropogenic mass reached unprecedented levels.
As of 2020, there is the same amount of mass embedded into man-made inanimate objects as the sum of every living being on the planet.
This is a striking perspective on the rates of change in the relationship between humanity and nature. It illustrates the absolute limits of the system that we live in and the uncertainty that our future holds.
One of the keys to solving humanity’s greatest challenges lies in how we utilize anthropogenic mass. But we have to make sure that it doesn’t extinguish the planet’s capacity to sustain life.
Is it possible to obtain all the mass that humanity needs without resorting to extractive exploitation and the contamination of our ecosystems? The answer is yes.
The Change we need
Bioprocessing, AKA using living cells or their components to obtain desired products, has proven to be the most efficient way to obtain materials sustainably.
However, today’s biomass production methods are inefficient. To develop bioprocesses that allow us to use alternative sources to produce the anthropogenic and biomass humanity needs, the installed capacity to produce biomass should be increased at least 450X.
Biopharma, in particular, is fundamental to supply the therapeutic needs of society and contain health threats. This industry is facing unprecedented growth and biomanufacturing will become the biggest bottleneck in the value chain.
We need bold solutions so that the biomanufacturing industry can be the bridge between the prosperity of nature and the prosperity of humanity.
So we set out to reinvent how we implement bioprocesses incorporating state-of-the-art technologies.
Grown
Stämm Grown facilitates the implementation of cell growth systems globally.
Until today, more than 100 years after the implementation of large-scale industrial bioprocesses, this technology continues to be confined to very few spaces. For biotech to solve humanity’s greatest challenges, we need as many people as possible to be able to articulate biology-based solutions.
Wired
Stämm Wired provides full traceability of every node in the Grown network, gathering performance data in real-time.
The biotech industry 4.0 is becoming a reality, where an interdisciplinary team can carry out the entire development process of a biotech product from the cloud. We see great value in building a community of experts that can catalyze and operate the growth of this industry
To achieve this, it´s key to translate and simplify the language of biomanufacturing as it has been done for coding. We need a technology platform and a design language that expands the number of people thinking about bioprocesses.
Coded
Stämm Coded transforms our database into knowledge.
This enhances our understanding of cells, allowing us to predict the behavior of specific cell lines within our Bioprocessors.